Kingsley Biotechnology Co., Ltd. announced today that its subsidiary Baisjie Biotech has completed an automated intelligent production line for sweet protein in Jinan, China. This marks the official completion of the world's first commercial production line specially designed for sweet protein. It also shows that BaiSJ completed a strategic leap forward on the basis of the original industrial production capacity of sweet protein products, took the lead in completing the entire industry chain, and became the only industry leader with independent dedicated line mass production capacity in the global field of synthetic biological sweet protein. With the completion of this automated production line, Brazzein Brazilian sweet protein, the first domestic product to obtain GRAS certification from the US Food and Drug Administration, officially entered a new stage of industrial-grade large-scale mass production.

Kingsley Biotechnology Co., Ltd. announced today that its subsidiary Baisjie Biotech has completed an automated intelligent production line for sweet protein in Jinan, China. This marks the official completion of the world's first commercial production line specially designed for sweet protein. It also shows that BaiSJ completed a strategic leap forward on the basis of the original industrial production capacity of sweet protein products, took the lead in completing the entire industry chain, and became the only industry leader with independent dedicated line mass production capacity in the global field of synthetic biological sweet protein. With the completion of this automated production line, Brazzein Brazilian sweet protein, the first domestic product to obtain GRAS certification from the US Food and Drug Administration, officially entered a new stage of industrial-grade large-scale mass production.